| COVID-19 and risks to the supply and quality of tests, drugs, and vaccines PN Newton, KC Bond, M Adeyeye, M Antignac, A Ashenef, GR Awab, ... The Lancet Global Health 8 (6), e754-e755, 2020 | 158 | 2020 |
| The limitations of QALY: a literature review D Pettitt, S Raza, B Naughton, A Roscoe, A Ramakrishnan, A Ali, ... Journal of Stem Cell Research and Therapy 6 (4), 2016 | 141 | 2016 |
| Oxford handbook of clinical pharmacy P Wiffen, M Mitchell, M Snelling, N Stoner Oxford university press, 2017 | 69 | 2017 |
| A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality D McManus, BD Naughton BMJ global health 5 (8), e002393, 2020 | 66 | 2020 |
| Medicine authentication technology as a counterfeit medicine-detection tool: a Delphi method study to establish expert opinion on manual medicine authentication technology in … B Naughton, L Roberts, S Dopson, D Brindley, S Chapman BMJ open 7 (5), e013838, 2017 | 42 | 2017 |
| Global access to quality-assured medical products: the Oxford Statement and call to action PN Newton, KC Bond, P Newton, K Bond, V Abiola, K Ade-Abolade, ... The Lancet Global Health 7 (12), e1609-e1611, 2019 | 36 | 2019 |
| Effectiveness of medicines authentication technology to detect counterfeit, recalled and expired medicines: a two-stage quantitative secondary care study B Naughton, L Roberts, S Dopson, S Chapman, D Brindley BMJ open 6 (12), e013837, 2016 | 36 | 2016 |
| Megaproject leaders: Reflections on personal life stories N Drouin, A van Marrewijk, R Müller Edward Elgar Publishing, 2021 | 32 | 2021 |
| Responsible innovation in digital health T Iakovleva, EM Oftedal, J Bessant Responsible Innovation in Digital Health: Empowering the Patient; Iakovleva …, 2019 | 29 | 2019 |
| The European Falsified Medicines Directive in Poland: background, implementation and potential recommendations for pharmacists P Merks, D Swieczkowski, M Byliniak, M Drozd, K Krupa, M Jaguszewski, ... European Journal of Hospital Pharmacy 25 (1), 10-15, 2018 | 22 | 2018 |
| Medicine authentication technology: a quantitative study of incorrect quarantine, average response times and offline issues in a hospital setting BD Naughton BMJ open 9 (2), e026619, 2019 | 21 | 2019 |
| Establishing good authentication practice (GAP) in secondary care to protect against falsified medicines and improve patient safety BD Naughton, JA Smith, DA Brindley European Journal of Hospital Pharmacy 23 (2), 118-120, 2016 | 21 | 2016 |
| EU Falsified Medicines Directive mandatory requirements for secondary care: a concise review BD Naughton, B Vadher, J Smith, G Smith, SR Chapman, S Dopson, ... Journal of Generic Medicines 12 (3-4), 95-101, 2015 | 13 | 2015 |
| The EU Falsified medicines directive: key implications for Dispensers BD Naughton Medicine Access@ Point of Care 1, maapoc. 0000024, 2017 | 11 | 2017 |
| Responsible impact and the reinforcement of responsible innovation in the public sector ecosystem: cases of digital health innovation B Naughton, S Dopson, T Iakovleva Journal of Responsible Innovation 10 (1), 2211870, 2023 | 9 | 2023 |
| What is the impact of antidepressant side effects on medication adherence among adult patients diagnosed with depressive disorder: A systematic review E Niarchou, LH Roberts, BD Naughton Journal of Psychopharmacology 38 (2), 127-136, 2024 | 6 | 2024 |
| Medicine quality in high-income countries: the obstacles to comparative prevalence studies BD Naughton, E Akgul Medicine Access@ Point of Care 5, 23992026211052272, 2021 | 6 | 2021 |
| The future of falsified and substandard medicine detection: digital methods to track and authenticate pharmaceutical products B Naughton Pathways for Prosperity Commission, 2018 | 6 | 2018 |
| & Brindley, DA (2016). The limitations of QALY: a literature review DA Pettitt, S Raza, B Naughton, A Roscoe, A Ramakrishnan, A Ali Journal of Stem Cell Research and Therapy 6 (4), 0 | 4 | |
| Responsible innovation and commercialisation in the university context: a case study of an academic entrepreneur in digital healthcare B Naughton, L Foss Responsible Innovation in Digital Health, 197-220, 2019 | 2 | 2019 |
